Gastric Bypass Cost in Piedras-Negras, Mexico

In 2026, gastric bypass in Piedras Negras typically costs between $5,500 and $7,800, which is significantly lower than prices in the United States and Canada due to lower overhead.

The lower cost is due to reduced administrative expenses, lower labor costs, and favorable exchange rates in Mexico, rather than a reduction in the quality of medical care provided.

Most packages include the surgeon's fee, anesthesiology, hospital stay, pre-operative lab work, and ground transportation between the Eagle Pass, Texas border and the facility.

Piedras Negras is a common destination for medical tourists due to its proximity to the US border and modern facilities that adhere to international safety and hygiene standards.

Patients usually stay 2 to 3 days in the hospital. Most can return to light office work within 10 to 14 days, though full physical recovery takes approximately six weeks.

Candidates typically need a BMI of 40 or higher, or a BMI of 35 with obesity-related conditions. A full medical history review is required before scheduling the 2026 procedure.

Most patients fly into San Antonio, Texas, and use a shuttle service to cross the border at Eagle Pass, which leads directly into the medical district of Piedras Negras.

Most US private insurance plans do not cover surgery in Mexico. However, the total 2026 out-of-pocket cost is often lower than the co-pays or deductibles required in the US.

Patients receive comprehensive dietary guidelines and a follow-up schedule to share with their home physician to ensure long-term nutritional success and weight maintenance.

Patients can lose up to 70% of their excess body weight within the first year by following the post-surgical diet and lifestyle recommendations provided by the medical team.

Standard quotes cover the procedure and stay, but patients should budget for airfare, daily medications, and specialized bariatric vitamins required after the surgery.

The Roux-en-Y is considered the gold standard for weight loss in 2026, offering superior results for diabetes resolution and long-term weight control compared to restrictive options.